Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells
- PMID: 8350087
- DOI: 10.1021/np50096a007
Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells
Abstract
A series of artemisinin-related endoperoxides was tested for cytotoxicity to Ehrlich ascites tumor (EAT) cells using the microculture tetrazolium (MTT) assay. Artemisinin [1] had an IC50 value of 29.8 microM. Derivatives of dihydroartemisinin [2], being developed as antimalarial drugs (artemether [3], arteether [4], sodium artesunate [5], artelinic acid [6], and sodium artelinate [7]), exhibited a somewhat more potent cytotoxicity. Their IC50 values ranged from 12.2 to 19.9 microM. The presence of an exocyclic methylene fused to the lactone ring, as for artemisitene [9], led to higher cytotoxicity than 1. From the two epimeric 11-hydroxyartemisinin derivatives, the R form 12 showed a considerably higher cytotoxicity than the S form 13. Opening of the lactone ring of 1 dramatically reduced the cytotoxicity. The ether dimer 8 of 2 was the most potent cytotoxic agent, its IC50 being 1.4 microM. The variations in cytotoxicity between the structurally related compounds mostly correlated well with the theoretical capacity of radical formation and stabilization. In some cases lipophilicity or the presence of an electrophilic moiety seemed to have a determinant influence on cytotoxicity. The artemisinin-related endoperoxides showed cytotoxicity to EAT cells at higher concentrations than those needed for in vitro antimalarial activity, as reported in the literature.
Similar articles
-
Stereochemistry-dependent cytotoxicity of some artemisinin derivatives.J Nat Prod. 1997 Apr;60(4):325-30. doi: 10.1021/np9605495. J Nat Prod. 1997. PMID: 9134741
-
Stability of artemisinin in aqueous environments: impact on its cytotoxic action to Ehrlich ascites tumour cells.J Pharm Pharmacol. 1997 Dec;49(12):1254-8. doi: 10.1111/j.2042-7158.1997.tb06080.x. J Pharm Pharmacol. 1997. PMID: 9466353
-
Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells.Planta Med. 1998 Oct;64(7):615-9. doi: 10.1055/s-2006-957533. Planta Med. 1998. PMID: 9810267
-
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708. Infect Disord Drug Targets. 2013. PMID: 24304352 Review.
-
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.Microbiol Rev. 1996 Jun;60(2):301-15. doi: 10.1128/mr.60.2.301-315.1996. Microbiol Rev. 1996. PMID: 8801435 Free PMC article. Review.
Cited by
-
Sesquiterpenes from Artemisia annua and Their Cytotoxic Activities.Molecules. 2022 Aug 10;27(16):5079. doi: 10.3390/molecules27165079. Molecules. 2022. PMID: 36014318 Free PMC article.
-
Discovery and repurposing of artemisinin.Front Med. 2022 Feb;16(1):1-9. doi: 10.1007/s11684-021-0898-6. Epub 2022 Mar 15. Front Med. 2022. PMID: 35290595 Free PMC article. Review.
-
Artesunate Suppresses the Growth of Lung Cancer Cells by Downregulating the AKT/Survivin Signaling Pathway.Biomed Res Int. 2022 Mar 25;2022:9170053. doi: 10.1155/2022/9170053. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2023 Dec 29;2023:9876410. doi: 10.1155/2023/9876410. PMID: 35372571 Free PMC article. Retracted.
-
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds.Molecules. 2018 Apr 6;23(4):841. doi: 10.3390/molecules23040841. Molecules. 2018. PMID: 29642419 Free PMC article.
-
Artemisinin and its derivatives: a promising cancer therapy.Mol Biol Rep. 2020 Aug;47(8):6321-6336. doi: 10.1007/s11033-020-05669-z. Epub 2020 Jul 24. Mol Biol Rep. 2020. PMID: 32710388 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources